TB and sickle cell therapies receive fast-track vouchers under new FDA program While faster reviews could bring life-saving treatments to patients sooner, compressed timelines could also limit regulatory scrutiny and strain FDA resources.

https://www.drugdiscoverynews.com/tb-and-sickle-cell-therapies-receive-fast-track-vouchers-under-new-fda-program-16925